Unhealthy dietary habits, including processed foods, high salt intake, and sugary drinks, are fueling the rise of stomach and ...
Researchers sought to determine trends and future patterns for liver, pancreatic, colorectal, stomach, and esophageal cancers in the US.
Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, ...
Marwan G. Fakih, MD, provides an overview of the study design, rationale, and findings from a phase 2 trial of balstilimab with botensilimab for the treatment of patients with microsatellite stable ...
A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...
Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...
A study showed Cabometyx improved time before disease progression in advanced digestive NETs compared with placebo.
Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...
Dr. Scott Kopetz discusses the BREAKWATER trial investigating Braftovi and Erbitux plus chemo in those with BRAF V600E+ ...
Alexander I. Spira, MD, PhD, FACP, discusses the clinical implications of ctDNA for treatment decisions and monitoring in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback